,
Arias-Vásquez, A. https://orcid.org/0000-0002-4786-0169
Groffen, A. J.
Spijker, S.
Ouwens, K. G.
Klein, M.
Vojinovic, D.
Galesloot, T. E.
Bralten, J.
Hottenga, J. J.
van der Most, P. J.
Kattenberg, V. M.
Pool, R.
Nolte, I. M.
Penninx, B. W. J. H.
Fedko, I. O.
Dolan, C. V.
Nivard, M. G.
den Braber, A.
van Duijn, C. M.
Hoekstra, P. J.
Buitelaar, J. K.
Kiemeney, L. A.
Hoogman, M.
Middeldorp, C. M.
Draisma, H. H. M.
Vermeulen, S. H.
Sánchez-Mora, C.
Ramos-Quiroga, J. A.
Ribasés, M.
Hartman, C. A.
Kooij, J. J. S.
Amin, N.
Smit, A. B.
Franke, B.
Boomsma, D. I.
Article History
Received: 17 March 2018
Accepted: 26 December 2018
First Online: 18 January 2019
Compliance with ethical standards
:
: J.K.B. has been in the past 3 years a consultant to/member of advisory board of/and/or speaker for Janssen Cilag BV, Eli Lilly, Shire, Lundbeck, Roche and Servier. He is not an employee of any of these companies, and not a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents, royalties. J.J.S.K. has been a speaker for Eli Lilly, Janssen and Shire until 2012, and received unrestricted research grants in 2010 from Janssen and Shire. J.A.R.Q. was on the speakers’ bureau and/or acted as consultant for Eli-Lilly, Janssen-Cilag, Novartis, Shire, Lundbeck, Ferrer and Rubió in the last 3 years. He also received travel awards (air tickets + hotel) for taking part in psychiatric meetings from Janssen-Cilag, Rubió, Shire and Eli-Lilly. The ADHD Program chaired by him received unrestricted educational and research support from the following pharmaceutical companies in the last 3 years: Eli-Lilly, Janssen-Cilag, Shire, Rovi and Rubió. B.F. received educational speaking fees from Shire and Medice. A.A.V., A.J.G., H.H.M.D., M.K., D.V., S.S., T.E.G., J.J.H., P.J.vdM., V.M. K, R.P., I.M.N., B.W.J.H.P., I.O.F, A.dB., C.M.vD., P.J.H., L.A.K., M.H, M.K., C.M.M., K.G.O., S.H.V., C.S.M., M.R., C.A.H., N.A., A.B.S., D.I.B. report no conflict of interest.